Two Types of B-Cells Identified

Two Distinct Types of Diffuse Large B-Cell Lymphoma (DLBCL) Identified By Gene Expression Profiling. Using DNA microarrays, researchers have…

More...

Drug Effective in Hodgkins

Brentuximab Vedotin Is Effective in Hodgkin Lymphoma, American Association for Cancer Research. A phase II study evaluated safety…

More...

The 2012 Global Lymphoma Patient Survey is available online now for your participation.

More...

Phase 3 Trial of brentuximab vedotin Initiated in Patients with Relapsed CTCL A global multi-centre phase 3 study…

Spectrum Pharmaceuticals said it agreed to acquire Allos Therapeutics. Spectrum, presently developing the Zevalin market, will be adding Folotyn to its oncology line up.

Read more...
In March, Celgene Corporation announced it completed its acquisition of Avila Therapeutics.

Read more...

Looking for lymphoma information in another language? Many of the LC member organizations publish lymphoma news, research and information in other languages.
Read more...
The Leukaemia & Blood Foundation New Zealand operates and administers the New Zealand Bone Marrow Donor Registry. They are assisted in this role by their close relationship with the New Zealand Blood Service.
Read more...

Journal of Investigative Dermatology

Effective biomedical investigation does not begin and end with the investigators who work in laboratories; rather, successful investigation requires a diverse array of “stakeholders.”
Read more...
H-E-L-P!

Healthy Exercise for Lymphoma Patients - It was found that 46% of lymphoma patients in the exercise group had a complete response to their chemotherapy compared to just 31% in the usual care group.
Read more...